Publications

Full details of Andy’s publications are available at his Google Scholar Page

Check out Andy’s ResearchGate or ORCiD profiles.


2017

Vella LJ, Behren A, Coleman B, Greening DW, Hill AF, Cebon J. Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle-Associated PDGFRβ. Neoplasia. 2017 Sep 27;19(11):932-940.

Vella LJ, Coleman B, Hill AF. Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay. Methods Mol Biol. 2017;1658:105-118. doi: 10.1007/978-1-4939-7244-9_9.

Bellingham SA, Hill AF. Analysis of miRNA Signatures in Neurodegenerative Prion Disease. Methods Mol Biol. 2017;1658:67-80. doi: 10.1007/978-1-4939-7244-9_6.

Vella LJ, Scicluna BJ, Cheng L, Bawden EG, Masters CL, Ang C-S, Williamson N, McLean C, Barnham KJ, Hill AF. A Rigorous method to enrich for exosomes from brain tissue. J Extracell Vesicles. 2017 26 July;6(1):1348885. doi:10.1080/20013078.2017.1348885.

Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, Lacroix R, Lee Y, van Leeuwen TG, Mackman N, Mäger I, Nolan JP, van der Pol E, Pegtel DM, Sahoo S, Siljander PRM, Sturk G, de Wever O, Nieuwland R. Methodological Guidelines to Study Extracellular Vesicles. Circ Res. 2017 May 12;120(10):1632-1648. doi: 10.1161/CIRCRESAHA.117.309417.

Lunavat TR, Cheng L, Einarsdottir BO, Olofsson Bagge R, Veppil Muralidharan S, Sharples RA, Lässer C, Gho YS, Hill AF, Nilsson JA, Lötvall J. BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells. Proc Natl Acad Sci U S A. 2017 Jul 6. pii: 201705206. doi: 10.1073/pnas.1705206114. [Epub ahead of print]

Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FW, Das S, Driedonks TA, Fernández-Messina L, Haderk F, Hill AF, Jones JC, Van Keuren-Jensen KR, Lai CP, Lässer C, Liegro ID, Lunavat TR, Lorenowicz MJ, Maas SL, Mäger I, Mittelbrunn M, Momma S, Mukherjee K, Nawaz M, Pegtel DM, Pfaffl MW, Schiffelers RM, Tahara H, Théry C, Tosar JP, Wauben MH, Witwer KW, Nolte-‘t Hoen EN. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles. 2017 Mar 7;6(1):1286095. doi: 10.1080/20013078.2017.1286095.

EV-TRACK Consortium., Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, Berx G, Boere J, Boukouris S, Bremer M, Buschmann D, Byrd JB, Casert C, Cheng L, Cmoch A, Daveloose D, De Smedt E, Demirsoy S, Depoorter V, Dhondt B, Driedonks TA, Dudek A, Elsharawy A, Floris I, Foers AD, Gärtner K, Garg AD, Geeurickx E, Gettemans J, Ghazavi F, Giebel B, Kormelink TG, Hancock G, Helsmoortel H, Hill AF, Hyenne V, Kalra H, Kim D, Kowal J, Kraemer S, Leidinger P, Leonelli C, Liang Y, Lippens L, Liu S, Lo Cicero A, Martin S, Mathivanan S, Mathiyalagan P, Matusek T, Milani G, Monguió-Tortajada M, Mus LM, Muth DC, Németh A, Nolte-‘t Hoen EN, O’Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau Q, Sahoo S, Sampaio N, Samuel M, Scicluna B, Soen B, Steels A, Swinnen JV, Takatalo M, Thaminy S, Théry C, Tulkens J, Van Audenhove I, van der Grein S, Van Goethem A, van Herwijnen MJ, Van Niel G, Van Roy N, Van Vliet AR, Vandamme N, Vanhauwaert S, Vergauwen G, Verweij F, Wallaert A, Wauben M, Witwer KW, Zonneveld MI, De Wever O, Vandesompele J, Hendrix A. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nature Methods. 2017 Feb 28;14(3):228-232. doi: 10.1038/nmeth.4185.

Foers AD, Cheng L, Hill AF, Wicks IP, Pang KC. Extracellular vesicles in joint inflammation. Arthritis Rheumatol. Arthritis Rheumatol. 2017 Jul;69(7):1350-1362.

Quek C, Bellingham SA, Jung CH, Scicluna B, Shambrook MC, Sharples R, Cheng L, Hill AF. Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery. RNA Biol. RNA Biol. 2017 Feb;14(2):245-258.

Cheng L, Hill AF. Small RNA Library Construction for Exosomal RNA from Biological Samples for the Ion Torrent PGM™ and Ion S5™ System. Methods Mol Biol. 2017;1545:71-90

Bellingham SA, Shambrook M, Hill AF. Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR. Methods Mol Biol. 2017;1545:55-70.

Quek C, Hill AF. The role of extracellular vesicles in neurodegenerative diseasesBiochem Biophys Res Commun. 2017 Feb 19;483(4):1178-1186.

2016

Howitt J, Hill AF. Exosomes in the Pathology of Neurodegenerative Diseases. J Biol Chem. 2016; 291 (52), 26589-26597.

Gardiner C, Di Vizio D, Sahoo S, Théry C, Witwer KW, Wauben M, Hill AF. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey.  J Extracell Vesicles. 2016 Oct 31;5:32945.

Vogel R, Coumans FA, Maltesen RG, Böing AN, Bonnington KE, Broekman ML, Broom MF, Buzás EI, Christiansen G, Hajji N, Kristensen SR, Kuehn MJ, Lund SM, Maas SL, Nieuwland R, Osteikoetxea X, Schnoor R, Scicluna BJ, Shambrook M, de Vrij J, Mann SI, Hill AF, Pedersen S. A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing. J Extracell Vesicles. 2016 Sep 27;5:31242. doi: 10.3402/jev.v5.31242.

Ugalde CL, Finkelstein DI, Lawson VA, Hill AF. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers. J Neurochem. 2016 Oct;139(2):162-180. doi: 10.1111/jnc.13772.

Krämer-Albers E-M, Hill AF. Extracellular vesicles: interneual shuttles of complex messages. Current Opinion in Neurobiology. 2016, doi: 10.1016/j.conb.2016.04.016

Cheung K-H, Keerthikumar S, Roncaglia P, Subramanian, Roth ME, Samuel M, Anand S, Gangoda L, Gould S, Alexander R, Galas D, Gerstein MB, Hill AF, Kitchen RR, Lotvall J, Patel T, Procaccini DC, Quesenbery P, Rozowsky J, Raffai RI, Shypitsyna A, Su AI, Thery C, Vickers K, Wauben MHM, Mathivanan S, Molisavljevic A, Laurent LC. Extending gene ontology in the context of extracellular RNA and vesicle communicationJ Biomed Seman. 2016 7:19

Polanco JC, Scicluna BJ, Hill AF, Gotz J. Extracellular vesicles isolated from brains of rTg4510 mice seed tau aggregation in a threshold-dependent mannerJ  Biol Chem. 2016 Mar 30. [Epub ahead of print]

François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer’s disease. Curr Alzheimer Res. 2016 Mar 15. [Epub ahead of print]

Silverman JM, Fernando SM, Grad LI, Hill AF, Turner BJ, Yerbury JJ, Cashman NR. Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent PathwaysCell Mol Neurobiol. 2016 Feb 23. [Epub ahead of print]

Cheng L, Quek CYJ, Hung LW, Sharples RA, Sherratt NA, Barnham KJ, Hill AF. Gene dysregulation is restored in the Parkinson’s disease MPTP neurotoxic mice model upon treatment of the therapeutic drug CuII(atsm). Scientific Reports | 6:22398 | DOI: 10.1038/srep22398 1

Vella LJ, Hill AF*, Cheng L. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease. International Journal of Molecular Sciences. 2016, 17(2), 173; doi:10.3390/ijms17020173 (*corresponding author)

Guo BB, Bellingham SA, Hill AF. Stimulating the release of exosomes increases the intercellular transfer of prions. J Biol Chem. 2016 Jan 14. pii: jbc.M115.684258. [Epub ahead of print]

Low H, Cheng L, Di Yacovo M-S, Churchill MJ, Meikle P, Bukrinsky M, Hill AF, Sviridov D. Lipid metabolism in patients infected with Nef-deficient HIV-1 strain. Atherosclerosis. 2016, 244;22-28.


2015

Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O’Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J Extracell Vesicles. 2015 Dec 31;4:30087.

Polling S, Ormsby AR, Wood RJ, Lee K, Shoubridge C, Hughes JN, Thomas PQ, Griffin MD, Hill AF, Bowden Q, Böcking T, Hatters DM. Polyalanine expansions drive a shift into α-helical clusters without amyloid-fibril formation. Nat Struct Mol Biol. 2015 Nov 16. doi: 10.1038/nsmb.3127. [Epub ahead of print] PubMed PMID: 26571108.

Quek C, Hung CH, Lonie A, Bellingham SA, Hill AF. iSRAP – a one-touch research tool for rapid profiling of small RNA-seq data. Journal of Extracellular Vesicles. 2015, 4: 29454 – http://dx.doi.org/10.3402/jev.v4.29454

De Mario A, Castellani A, Peggion C, Massimino ML, Lim D, Hill AF, Sorgato MC, Bertoli A. The prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase Frontiers in Cellular Neuroscience. 2015 http://dx.doi.org/10.3389/fncel.2015.00416

Lunavat TR, Cheng L, Kim D-K, Bhadury J, Jang SC, Lasser C, Sharples RA, Lopez MD, Nilsson J, Gho YS, Hill AF, Lotvall J. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells – evidence of unique microRNA cargos. RNA Biology. 2015 Aug 3;12(8):810-23.

Bellingham SA, Guo BB, Hill AF. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration. Biology of the Cell. 2015, June 1.

Sviridov D, Hill AF. Atherosclerosis: cell biology and lipoproteins. Not a day without microRNA. Current Opinion in Lipidology. 2015 Aug;26(4):355-6.

Pathan M, Keerthikumar S, Ang C-S, Gangoda L, Quek CYJ, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim A, Bacic A, Hill AF, Stroud DA, Ryan MT, Agbinya JI, Mariadasson JM, Burgess AW, Mathivanan S. FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015 Aug;15(15):2597-601.

Ellet LJ, Coleman BM, Shambrook M, Johanssen V, Collins SJ, Masters CL, Hill AF, Lawson VA. Glycosaminoglycan Sulfation Determines the Biochemical Properties of Prion Protein Aggregates. Glycobiology. 2015 Jul;25(7):745-55.

Coleman BM, Hill AF. Extracellular vesicles – their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Seminars in Cell and Developmental Biology. 2015 Feb 19. pii: doi: 10.1016/j.semcdb.2015.02.007.

Johanssen T, Suphantarida N, Donnelly PS, Liu ZM, Petrou S, Hill AF, Barnham KJ. PBT2 Inhibits Glutamate-induced Excitotoxicity in Neurons Through Metal-mediated Preconditioning. Neurobiology of Disease. 2015 Feb 17. pii: S0969-9961(15)00028-5.

Guo BB, Bellingham SA, Hill AF. The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem. 2015 Feb 6;290(6):3455-67.

Iqbal Hossain M, Hoque A, Lessene G, Aizuddin Kamaruddin M, Chu PW, Ng IH, Irtegun S, Ng DC, Bogoyevitch MA, Burgess AW, Hill AF, Cheng HC. Dual role of Src kinase in governing neuronal survival. Brain Res. 2015 Jan 12;1594:1-14. doi: 10.1016/j.brainres.2014.10.040.

Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, Kim SH, Park KS, Kim OY, Park HT, Seo JH, Aikawa E, Baj-Krzyworzeka M, van Balkom BW, Belting M, Blanc L, Bond V, Bongiovanni A, Borràs FE, Buée L, Buzás EI, Cheng L, Clayton A, Cocucci E, Dela Cruz CS, Desiderio DM, Di Vizio D, Ekström K, Falcon-Perez JM, Gardiner C, Giebel B, Greening DW, Gross JC, Gupta D, Hendrix A, Hill AF, Hill MM, Nolte-‘t Hoen E, Hwang DW, Inal J, Jagannadham MV, Jayachandran M, Jee YK, Jørgensen M, Kim KP, Kim YK, Kislinger T, Lässer C, Lee DS, Lee H, van Leeuwen J, Lener T, Liu ML, Lötvall J, Marcilla A, Mathivanan S, Möller A, Morhayim J, Mullier F, Nazarenko I, Nieuwland R, Nunes DN, Pang K, Park J, Patel T, Pocsfalvi G, Del Portillo H, Putz U, Ramirez MI, Rodrigues ML, Roh TY, Royo F, Sahoo S, Schiffelers R, Sharma S, Siljander P, Simpson RJ, Soekmadji C, Stahl P, Stensballe A, Stępień E, Tahara H, Trummer A, Valadi H, Vella LJ, Wai SN, Witwer K, Yáñez-Mó M, Youn H, Zeidler R, Gho YS. EVpedia: a community web portal for extracellular vesicles research. Bioinformatics. 2015 Mar 15;31(6):933-9.


2014

Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, Sahoo S, Tahara H, Wauben MH, Witwer KW, Théry C. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014 Dec 22;3:26913. doi:10.3402/jev.v3.26913. eCollection 2014. PubMed PMID: 25536934.

Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry. 2014 Oct 28. doi: 10.1038/mp.2014.127.

Lopes MH, Santos TG, Rodrigues BR, Queiroz-Hazarbassanov N, Cunha IW, Wasilewska-Sampaio AP, Costa-Silva B, Marchi FA, Bleggi-Torres LF, Sanematsu PI, Suzuki SH, Oba-Shinjo SM, Marie SK, Toulmin E, Hill AF, Martins VR. Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival. Oncogene. 2015 Jun;34(25):3305-14.

Cheng L, Sharples RA, Scicluna B, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014 Mar 26;3. doi: 10.3402/jev.v3.23743.

Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O’Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, Kumita JR, Luheshi L, Yousefi M, Coleman BM, Hill AF, Plotkin SS, Mackenzie IR, Cashman NR. Intercellular propagated misfolding of wild-type Cu-Zn superoxide dismutase occurs via exosome-dependent and independent mechanisms. Proc Natl Acad Sci USA. 2014 Mar 4;111(9):3620-5.

Polling S, Mok YF, Ramdzan YM, Turner BJ, Yerbury JJ, Hill AF, Hatters DM. Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell. J Biol Chem. 2014 Mar 7;289(10):6669-80.

Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF. Pathogenic Mutations within the Hydrophobic Domain of the Prion Protein Lead to the Formation of Protease-Sensitive Prion Species with Increased Lethality. J Virol. 2014 Mar;88(5):2690-703. doi: 10.1128/JVI.02720-13.

Johanssen VA, Johanssen T, Masters CL, Hill AF, Barnham KJ, Collins SJ. C-terminal peptides modelling constitutive PrPC processing demonstrate ameliorated toxicity predisposition consequent to α-cleavage. Biochem J. 2014 Apr 1;459(1):103-15. doi: 10.1042/BJ20131378.

Cui HL, Guo B, Scicluna B, Coleman BM, Lawson VA, Ellett L, Meikle PJ, Bukrinsky M, Mukhamedova N, Sviridov D, Hill AF. Prion infection impairs cholesterol metabolism in neuronal cells. J Biol Chem. 2014 Jan 10;289(2):789-802.


2013

Hill AF, Pegtel DM, Lambertz U, Leonardi T, O’Driscoll L, Pluchino S, Ter-Ovanesyan D, Nolte-‘t Hoen EN. ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22859.

Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int. 2014 Aug;86(2):433-44.

Hsiao JH, Fu Y, Hill AF, Halliday GM, Kim WS. Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation. PLoS One. 2013 Aug 20;8(8):e74016.

Bujalka H, Koenning M, Jackson S, Perreau VM, Pope B, Hay CM, Mitew S, Hill AF, Lu QR, Wegner M, Srinivasan R, Svaren J, Willingham M, Barres BA, Emery B. MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol. 2013;11(8):e1001625. Epub 2013 Aug 13.

Cheng L, Quek CY, Sun X, Bellingham SA, Hill AF. The detection of microRNA associated with Alzheimer’s disease in biological fluids using next-generation sequencing technologies. Front Genet. 2013 Aug 8;4:150.

Chia PZ, Toh WH, Sharples R, Gasnereau I, Hill AF, Gleeson PA. Intracellular itinerary of internalised β-secretase, BACE1, and its potential impact on β-amyloid peptide biogenesis. Traffic. 2013 Sep;14(9):997-1013.

Regev-Rudzki N, Wilson DW, Carvalho TG, Sisquella X, Coleman BM, Rug M, Bursac D, Angrisano F, Gee M, Hill AF, Baum J, Cowman AF. Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell. 2013 May 23;153(5):1120-33.

Hossain MI, Roulston CL, Kamaruddin MA, Chu PW, Ng DC, Dusting GJ, Bjorge JD, Williamson NA, Fujita DJ, Cheung SN, Chan TO, Hill AF, Cheng HC. A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity. J Biol Chem. 2013 Apr 5;288(14):9696-709.

Tauro BJ, Mathias RA, Greening DW, Gopal SK, Ji H, Kapp EA, Coleman BM, Hill AF, Kusebauch U, Hallows JL, Shteynberg D, Moritz RL, Zhu HJ, Simpson RJ. Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol Cell Proteomics. 2013 Aug;12(8):2148-59.


2012

Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borràs FE, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A, Cocucci E, Falcon-Perez JM, Gabrielsson S, Gho YS, Gupta D, Harsha HC, Hendrix A, Hill AF, Inal JM, Jenster G, Krämer-Albers EM, Lim SK, Llorente A, Lötvall J, Marcilla A, Mincheva-Nilsson L, Nazarenko I, Nieuwland R, Nolte-‘t Hoen EN, Pandey A, Patel T, Piper MG, Pluchino S, Prasad TS, Rajendran L, Raposo G, Record M, Reid GE, Sánchez-Madrid F, Schiffelers RM, Siljander P, Stensballe A, Stoorvogel W, Taylor D, Thery C, Valadi H, van Balkom BW, Vázquez J, Vidal M, Wauben MH, Yáñez-Mó M, Zoeller M, Mathivanan S. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012 Dec;10(12):e1001450

Klemm, HMJ, Welton JM, Masters CL, Hill AF, Collins SJ, Lawson VA. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. Journal of Biological Chemistry 2012 Oct 19;287(43):36465-72.

Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion infected neuronal cells. Nucleic Acids Research (2012) Nov;40(21):10937-49.

Coleman BM, Hanssen E, Lawson VA, Hill AF. Prion infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB Journal. 2012 Oct;26(10):4160-73.

Falsone SF, Meyer NH, Schrank E, Leitinger G, Pham CLL, Fodero-Tavoletti MT, Holmberg M, Nollen EA, Dulle M, Scicluna B, Gesslbauer B, Ruckert HM, Wagner G, Kungl AJ, Hill AF, Cappai R, Zangger K. SERF protein is a direct modifier of amyloid fiber assembly. Cell Reports. 2012; 2 (2), 358-371.

Tu E, Ang DKY, Bellingham SA, Hogan TV, Teng MWL, Smyth MJ, Hill AF, van Driel IR. Both IFNγ and IL-17 are important for the development of severe autoimmune gastritis. European Journal of Immunology. 2012; 42(10), 2574-2583.

Bellingham SA, Guo B, Coleman BM, Hill AF. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Frontiers in Physiology. 2012; 3, 1-12.

Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ. Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Molecular Neurodegeneration. 2012; 7(1):18.

Polling S, Hill AF, Hatters DM. Polyglutamine Aggregation in Huntington and Related Diseases. Adv Exp Med Biol. 2012;769:125-40.

Karas JA, Boland M, Haigh C, Johanssen VA, Hill AF, Barnham KJ, Collins SJ, Scanlon D. Microwave Synthesis of Prion Protein Fragments up to 111 Amino Acids in Length Generates Biologically Active Peptides. International Journal of Peptide Research and Therapy. (2012) 18:21-29.

Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lin SC, Leong S, Wilkins S, George J, Roberts B, Pham CL, Chiu FCK, Shackleford DM, Powell AK, Masters CL, Bush AI, O’Keefe GO, Culvenor JG, Cappai R, Cherny RA, Donnelly PS, Hill AF, Finkelstein DI, Barnham KJ. The hypoxia imaging agent, CuII(atsm), is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease. Journal of Experimental Medicine. 2012 Apr 9;209(4):837-54.

Li H, Evin G, Hill AF, Hung YH, Bush AI, Garner B. Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues. Clin Sci (Lond) 2012;122(9):409-19.

Houghton FJ, Bellingham SA, Hill AF, Bourges D, Ang DK, Gemetzis T, Gasnereau I, Gleeson PA. Arl5b is a Golgi-localised small G protein involved in the regulation of retrograde transport. Exp Cell Res. 2012; 318(5):464-77.

Johanssen VA, Barnham KJ, Masters CL, Hill AF, Collins SJ. Generating recombinant C-terminal prion protein fragments of exact native sequence. Neurochem Int. 2012 Feb;60(3):318-26.


2011

Kim WS, Hill AF, Fitzgerald ML, Freeman MW, Evin G, Garner B. Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity. J Alzheimers Dis. 2011;27(2):441-52.

Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G. Decreased Expression of GGA3 Protein in Alzheimer’s Disease Frontal Cortex and Increased Co-Distribution of BACE with the Amyloid Precursor Protein. Neurobiol Disease. 2011;43(1):176-83.

Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, McLean C. Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology. 2011 Feb;43(2):93-102.

Dinet V, An N, Ciccotosto GD, Bruban J, Maoui A, Bellingham SA, Hill AF, Andersen OM, Nykjaer A, Jonet L, Cappai R, Mascarelli F. APP involvement in retinogenesis of mice. Acta Neuropathol. 2011 Mar;121(3):351-63.

Vella LJ, Cappai R, Hill AF. The role of exosomes in the pathogenesis of prion infection. In The Cellular and Molecular Biology of Prion Disease, edited by SJ Collins and VA Lawson, Research Signpost, 2011.

Miles LA, Crespi GA, Han S, Hill AF, Parker MW. An Escherichia coli cell-free system for recombinant protein synthesis on a milligram scale. Methods Mol Biol. 2011;752:17-28.


2010

Lawson VA, Furness JB, Klemm HM, Pontell L, Chan E, Hill AF, Chiocchetti R. The brain to gut pathway: a possible route of prion transmission. Gut. 2010 Dec;59(12):1643-51.

Lawson VA, Lumicisi B, Welton J, Machalek D, Gouramanis K, Klemm HM, Stewart JD, Masters CL, Hoke DE, Collins SJ, Hill AF. Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein. PLoS One. 2010 Aug 23;5(8). pii: e12351.

Boland MP, Hatty CR, Separovic F, Hill AF, Tew DJ, Barnham KJ, Haigh CL, James M, Masters CL, Collins SJ. Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain. J Biol Chem. 2010 Oct 15;285(42):32282-92.

Li H, Kim WS, Guillemin GJ, Hill AF, Evin G, Garner B. Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochim Biophys Acta. 2010 Aug;1801(8):887-95.

Brazier MW, Volitakis I, Kvasnicka M, White AR, Underwood JR, Green JE, Han S, Hill AF, Masters CL, Collins SJ. Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. J Neurochem. 2010 Jul;114(2):440-51.

Olshina MA, Angley LM, Ramdzan YM, Tang J, Bailey MF, Hill AF, Hatters DM. Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. J Biol Chem. 2010 Jul 9;285(28):21807-16.

Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, Hill AF. Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol. 2010 Jul;84(13):6678-86.

Ramdzan YM, Nisbet RM, Miller J, Finkbeiner S, Hill AF, Hatters DM. Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem Biol. 2010 Apr 23;17(4):371-9.

Perreau VM, Orchard S, Adlard PA, Bellingham SA, Cappai R, Ciccotosto GD, Cowie TF, Crouch PJ, Duce JA, Evin G, Faux NG, Hill AF, Hung YH, James SA, Li QX, Mok SS, Tew DJ, White AR, Bush AI, Hermjakob H, Masters CL. A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer’s disease. Proteomics. 2010 Jun;10(12):2377-95.

Harrison CF, Lawson VA, Coleman BM, Kim YS, Masters CL, Cappai R, Barnham KJ, Hill AF. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity. J Biol Chem. 2010 Jun 25;285(26):20213-23.

Tabrett CA, Harrison CF, Schmidt B, Bellingham SA, Hardy T, Sanejouand YH, Hill AF*, Hogg PJ. Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function. Biochem J. 2010 May 13;428(2):169-82. (* corresponding author).


2009

Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. J Neuropathol Exp Neurol. 2009 Oct;68(10):1125-35.

Haigh CL, Lewis VA, Vella LJ, Masters CL, Hill AF, Lawson VA, Collins SJ. PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Res. 2009 Sep;19(9):1062-78.

Hill AF. Exosomes in Neurological Disease. Curr Med Literature Neurology. 2009;16(1);27-32.

Pham CL, Leong SL, Ali FE, Kenche VB, Hill AF, Gras SL, Barnham KJ, Cappai R. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J Mol Biol. 2009 Apr 3;387(3):771-85.

Coleman BM, Nisbet RM, Han S, Cappai R, Hatters DM, Hill AF. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. Biochem Biophys Res Commun. 2009 Mar 13;380(3):564-8.

Leong SL, Pham CL, Galatis D, Fodero-Tavoletti MT, Perez K, Hill AF, Masters CL, Ali FE, Barnham KJ, Cappai R. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radic Biol Med. 2009 May 15;46(10):1328-37.

Bellingham SA, Coleman LA, Masters CL, Camakaris J, Hill AF. Regulation of prion gene expression by transcription factors SP1 and MTF-1. J Biol Chem. 2009 Jan 9;284(2):1291-301.

Kim WS, Chan SL, Hill AF, Guillemin GJ, Garner B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons, Journal of Alzheimers Disease. 2009;16(1):121-31.


2008

Lawson VA, Vella L, Stewart JD, Sharples R, Klemm H, Machalek DM, Masters CL, Cappai R, Collins SJ, Hill AF. Mouse adapted sporadic human CJD prions propagate in cell culture. International Journal of Biochemistry and Cell Biology. 2008;40(12):2793-801.

Vella L, Greenwood D, Cappai R, Scheerlinck JPS, Hill AF. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Veterinary Immunology and Immunopathology. 2008, 124:385-393.

Chan SL, Kim WS, Kwok JB, Hill AF, Cappai R, Rye K, Garner B. ATP-binding cassette transporter A7 inhibits amyloid beta production in vitro. Journal of Neurochemistry. 2008 Jul;106(2):793-804.

Collinge J, Whitfield J, McKintosh E, Frosh A, Mead S, Hill AF, Brandner S, Thomas D, Alpers MP. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Trans. R. Soc. B. 2008 Nov 27;363(1510):3725-39.

Albanese V, Lawson VA, Hill AF, Cappai R, Di Guardo G, Staikopoulos V, Thacker M, Furness JB, Chiocchetti R. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine. Auton Neurosci. 2008 Jun;140(1-2):17-23.

Price KA, Filiz G, Caragounis A, Du T, Laughton K, Masters CL, Sharples RA, Hill AF, Li QX, Donnelly P, Barnham KJ, Crouch PJ, White AR. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide. International Journal of Biochemistry & Cell Biology. 2008;40(9):1901-17.

Wadsworth JDF, Joiner S, Linehan JM, Desbruslais M, Fox M, Cooper S, Cronier S, Asante EA, Mead S, Brander S, Hill AF, Collinge J. Kuru prions and sporadic CJD prions have equivalent transmission properties in transgenic and wild type mice. Proceedings of the National Academy of Sciences USA. 2008 Mar 11;105(10):3885-90.

Naylor, R, Hill AF, Barnham KJ. Is Covalently Crosslinked A-beta Responsible for Synaptotoxicity in Alzheimer’s Disease? Current Alzheimer Research. 2008 5(6); 533-539.

Vella LJ, Hill AF. Generation of cell lines propagating infectious prions and the isolation of cell derived exosomes. Methods Mol Biol. 2008;459:69-82.

Han S, Hill AF. Analysis of PrP conformation using circular dichroism. Methods Mol Biol. 2008;459:145-59.

Lewis V, Klug GM, Hill AF, Collins SJ. Molecular typing of PrPres in human sporadic CJD brain tissue. Methods Mol Biol. 2008;459:241-7.

Smith DP, Tew DJ, Hill AF, Bottomley SP, Masters CL, Barnham KJ, Cappai R. Formation of a High Affinity Lipid-Binding Intermediate during the Early Aggregation Phase of alpha-Synuclein. Biochemistry. 2008 Feb 5;47(5):1425-1434.

Sharples RA, Vella LJ, Nisbet RM, Naylor R, Perez K, Barnham KJ, Masters CL, Hill AF. Inhibition of {gamma}-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J. 2008 May;22(5):1469-78.

Courageot MP, Daude N, Nonno R, Paquet S, Di Bari MA, Le Dur A, Chapuis J, Hill AF, Agrimi U, Laude H, Vilette D. A cell line infectible by prion strains from different species. J Gen Virol. 2008 Jan;89(Pt 1):341-7.

Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, Sharples RA, Hill AF, Li QX, Masters CL, Barnham KJ, White AR. Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer’s disease amyloid-beta peptide. J Biol Chem. 2008 Feb 22;283(8):4568-77.

Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J. 2008 Mar;37(3):323-32.

Naylor R, Hill AF, Barnham KJ. Neurotoxicity in Alzheimer’s disease: is covalently crosslinked Abeta responsible? Eur Biophys J. 2008 Mar;37(3):265-8.


2007

Harrison CF, Barnham KJ, Hill AF. Neurotoxic species in prion disease: a role for PrP isoforms? J Neurochem. 2007 Dec;103(5):1709-20.

Caragounis A, Du T, Filiz G, Laughton KM, Volitakis I, Sharples RA, Cherny RA, Masters CL, Drew SC, Hill AF, Li QX, Crouch PJ, Barnham KJ, White AR. Differential modulation of Alzheimer’s disease amyloid beta-peptide accumulation by diverse classes of metal ligands. Biochem J. 2007 Nov 1;407(3):435-50.

Kim WS, Suryo Rahmanto A, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, Jessup W, Hill AF, and Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amyloid-beta peptide generation. J Biol Chem. 2007;282(5):2851-61.

Hill, A.F., Barnham, K.J., Response to Ji et al: why prion diseases are precluded by non-mammals. Trends Biochem.Sci. 32, 208-208 (2007).

Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, and Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. Journal of Pathology 2007 Apr;211(5):582-90.


2006

Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, and Cheng HC. C-terminal truncation and Parkinson’s disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet. 2006, 15(21):3251-62.

White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, and Masters CL. Degradation of the Alzheimer Disease Amyloid beta-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity. J Biol Chem. 2006 Jun 30;281(26):17670-80.

Wilson LM, Pham CLL, Jenkins AJ, Wade JD, Hill AF, Perugini MA, Howlett GJ. High density lipoproteins bind Aβ and apolipoprotein C-II amyloid fibrils. Journal of Lipid Research. 2006 Apr;47(4):755-60.

Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A, Poulter M, Wadsworth JDF, Collinge J. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain. 2006 Mar;129(Pt 3):676-85.

Barnham KJ, Cappai R, Beyreuther K, Masters CL, Hill AF. Delineating common molecular mechanisms in Alzheimer’s and prion diseases. Trends in Biochemical Sciences. 2006, 31(8):465-72.

Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins SJ. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Research Bulletin. 2006 Jan 30;68(5):346-54.


2005

Collins S.J., Lewis V.L., Brazier M.W., Hill AF, Lawson V.A., Klug G.M., Masters C.L., Extended period of asymptomatic prion (Creutzfeldt-Jakob disease) infection after low dose inoculation: assessment of detection methods and implications for infection control. Neurobiology of Disease. 2005, 20(2):336-346.

Lawson V.A., Collins S.J., Masters C.L., Hill AF Prion protein glycosylation. Journal of Neurochemistry. 2005, 93; 793-801.

Yuan, FF; Biffin, S; Brazier, MW; Suarez, M; Cappai, R; Hill, AF; Collins, SJ; Sullivan, JS; Middleton, D; Multhaup, G; Geczy, AF; Masters, CL. 2005. Detection of prion epitopes on PrPC and PrPSc of transmissible spongiform encephalopathies using monoclonal antibodies to PrP. Immunology and Cell Biology. 2005, 83 (6): 632-637.

Lewis V., Hill AF, Klug G., Boyd A., Masters C.L., Collins S.J., Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. 2005, 65(1):113-118.

Cappai R., Leck S-L., Tew D.J., Williamson N.A., Smith D.P., Galatis D., Sharples R.A., Curtain C.C., Ali F.E., Cherny R.A., Culvenor J.G., Bottomley S.P., Masters C.L., Barnham K.J., Hill AF. Dopamine promotes α–synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB Journal. 2005, 19(8).

Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neuroscience. 2005; 25(1):108-17.


2004

Wadsworth, J.D., Asante, E.A., Debruslais, M., Linehan, J.M., Joiner, S., Gowland, I., Welch, J., Stone, L., Lloyd, S.E., Hill, A.F., Brandner, S., and Collinge, J. Human prion protein V129 prevents expression of variant CJD phenotype. Science. 2004 Dec 3;306(5702):1793-6.

Hill AF, Identification of a new prion strain in cattle – is there more than one form of BSE? Australian Veterinary Journal, 2004; 82(5), 17-20.

Hill AF, Collinge J. Prion strains and species barriers. Contributions to Microbiology, 2004;11, 33-49.


2003

Hill AF, Collinge J. Subclinical prion infection. Trends in Microbiology. 2003;11(12):578-84. (cover article).

Nunan J, Williamson N.A., Hill AF, Sernee M.F., Masters C.L., Small D.H. Proteasome-mediated degradation of the C-terminus of the Alzheimer’s disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein. J Neurosci Res. 2003;74(3):378-85.

Lewis V, Collins, S., Hill, A.F., Boyd A., McLean, C.A., Smith M., and Masters C.L., Novel prion protein insert mutation associated with prolonged neurodegenerative illness. Neurology 2003, 60(10), 1620-4, 2003.

Hill, A.F., Asante, E., and Collinge, J. Bioassays for prions. In Prions and Mad Cow Disease, edited by Brian Nunnally and Ira Krull, Dekker Press, New York, 2003.

Wadsworth J.D., Hill AF, Beck J.A., Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull. 2003;66:241-54.

Hill AF, Collinge J. Subclinical prion infection in humans and animals. Br Med Bull. 2003;66:161-70.

Hill, A.F., Joiner, S., Wadsworth, J.D.F., Sidle, K.C.L., Bell, J.E., Budka, H., Ironside, J., and Collinge, J. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003, 126: 1333-46.

Hill, A.F. Possible link between bovine spongiform encephalopathy and sporadic Creutzfeldt-Jakob disease. Australian Veterinary Journal, 275-6, 81(5), 2003.


2002

Asante E., Linehan J.M., Desbruslais M., Joiner S., Gowland I., Wood A.L., Welch J., Hill AF, Lloyd S.E., Wadsworth J.D.F., and Collinge J. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002;21(23):6358-66.

Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Annals of Neurology. 2002 Oct;52(4):503-6.

Hill, A.F., and Collinge, J. Species barrier independent prion replication in apparently resistant species. APMIS 2002;110:44-53.

Collins, S., Boyd, A., Fletcher, A., Kaldor, J, Hill, A.F., Farish, S., McLean, C., Ansari, A., Smith, M., and Masters, C.L. Creutzfeldt-Jakob disease cluster in an Australian rural city. Annals of Neurology 2002 Jul;52(1):115-8. (IF: 7.7)


2001

Wadsworth, J.D.F., Joiner, S., Hill, A.F., Campbell, T.A., Desbruslais, M., and Collinge, J. Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 2001;358:171-180.

Hill AF, Collinge J. Strain variations & species barriers. Contributions to Microbiology 2001;7:48-57.

White, A.R., Guirguis, R., Brazier, M.W., Jobling, M.F., Hill, A.F., Beyreuther, K., Barrow, C.J., Masters, C.L., Collins, S.J., Cappai, R. Sub-lethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimers disease activates expression of pro-apoptotic markers in primary cortical neurons. Neurobiology of Disease 2001;8:299-316.


2000

Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 2000;97:10248-53.


1999

Almer, G., Hainfellner, J.A., Brucke, T., Jellinger, K., Kleinert, R., Bayer, G., Windl, O., Kretzschmar, H.A., Hill, A.F., Sidle, K., Collinge, J., and Budka, H. Fatal Familial Insomnia: A New Austrian Family. Brain 1999;122:5-16.

Hill, A.F., Antoniou, M., and Collinge, J. Protease resistant prion protein produced in vitro lacks detectable infectivity. Journal of General Virology 1999;80:11-14.

Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-189.

Jackson GS, Hosszu LP, Power A, Hill AF, Kenney J, Saibil H, Craven CJ, Waltho JP, Clarke AR, Collinge J. Reversible Conversion of Monomeric Human Prion Protein Between Native and Fibrillogenic Conformations. Science 1999;283:1953-1957.

Jackson, G.S., Hill, A.F., Joseph, C., Hosszu, L., Power, A., Waltho, J.P., Clarke, A.R., and Collinge, J. Multiple Folding Pathways for Heterologously Expressed Human Prion Protein. Biochem Biophys Acta 1999;1431:1-13.

Wadsworth, J.D.F., Hill, A.F., Joiner, S., Jackson, G.S., Clarke, A.R., and Collinge, J. Strain-specific prion-protein conformation determined by metal ions. Nature Cell Biology 1999;1:55-59.

Wadsworth, J.D.F., Jackson, G.S., Hill, A.F., and Collinge, J. Molecular biology of prion propagation. Current Opinion in Genetics & Development 1999;9:338-345.


1998

Piccardo, P., Langeveld, J.P.M., Hill, A.F., Dlouhy, S.R., Young, K., Giaccone, G., Rossi, G., Bugiani, M., Bugiani, O., Meloen, R.H., Collinge, J., Tagliavini, F., and Ghetti, B. An Antibody Raised Against a Conserved Sequence of the Prion Protein Recognises Pathological Isoforms in Human and Animal Prion Diseases, Including Creutzfeldt-Jakob Disease and BSE. American Journal of Pathology 1998;152:1415-1420.

Jackson, G., Hill, A.F., Joseph, C., Clarke, A., and Collinge, J. Structural properties of recombinant human prion protein. In Prions and Brain Diseases in Animals and Humans, edited by Morrison, Plenum Press, New York, 1998, pp197-202.

Hill, A.F., Sidle, K.C.L., Joiner, S., Keyes, P., Martin, T.C., Dawson, M., and Collinge, J. Molecular screening of sheep for bovine spongiform encephalopathy. Neuroscience Letters 1998;255:159-162.


1997

Collinge, J., Hill, A.F., Sidle, K.C.L., and Ironside, J. Typing prion isoforms. Nature 1997;386:233-234.

Deslys JP, Lasmézas CI, Streichenberger N, Hill AF, Collinge J, Dormont D, Kopp N. New variant Creutzfeldt-Jakob disease in France. Lancet 1997;349:30-31.

Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.

Hill, A.F., Desbruslais, M., Joiner, S., Sidle, K.C.L., Gowland, I., Doey, L.J., Lantos, P., and Collinge, J. The same prion strain causes vCJD and BSE. Nature 1997;389:448-450.

Hill AF, Will RG, Ironside J, Collinge J. Type of prion protein in UK farmers with Creutzfeldt-Jakob Disease. Lancet 1997;350:188.

Collinge, J; Hill, AF; Ironside, J; Zeidler, M. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy – Reply. Lancet. 1997: 349 (9061), 1323.

Collinge, J., Hill, A.F., Sidle, K.C.L., and Ironside, J. Biochemical typing of scrapie strains – reply. Nature 1997;386:564.


1996

Collinge, J., Sidle, K.C.L., Meads, J., Ironside, J., Hill AF. Molecular Analysis of prion strain variation and the aetiology of ‘new variant’ CJD.Nature (1996) :383;685-690.


1995

Whittington, M.A., Sidle, K.C.L., Gowland, I., Meads, J., Hill, A.F., Palmer, M.S., Jefferys, J.G.R., and Collinge, J. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genetics 1995:9;197-201.

Collinge, J., Palmer, M.S., Sidle, K.C.L., Hill, A.F., Gowland, I., Meads, J., Asante, E., Bradley, R., Doey, L.J., and Lantos, P.L. Unaltered susceptibility to BSE in transgenic mice expressing human PrP. Nature 1995:378;779-783.


1993

Palmer, M.S., Mahal, S.P., Campbell, T.A., Hill, A.F., Sidle, K.C.L., Laplanche, J.L., and Collinge, J. Deletions in the prion protein gene are not associated with CJD. Human Molecular Genetics 1993:2:541-544.


 

Comments are closed